State Street Corp Terns Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,116,991 shares of TERN stock, worth $6.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,116,991

Previous 1,176,833 5.09%

Holding current value

$6.48 Million

Previous $8.01 Million 16.23%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.49 - $10.8 $388,374 - $646,293	-59,842 Reduced 5.09%	1,116,991 $9.32 Million
Q2 2024 Aug 14, 2024	BUY	$4.54 - $8.2 $1.23 Million - $2.22 Million	271,339 Added 29.97%	1,176,833 $8.01 Million
Q1 2024 May 15, 2024	BUY	$4.86 - $8.19 $90,468 - $152,456	18,615 Added 2.1%	905,494 $5.94 Million
Q4 2023 Feb 14, 2024	BUY	$3.37 - $6.86 $29,251 - $59,544	8,680 Added 0.99%	886,879 $5.76 Million
Q3 2023 Nov 14, 2023	BUY	$4.7 - $8.55 $270,141 - $491,428	57,477 Added 7.0%	878,199 $4.42 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.29 $5.16 Million - $9.33 Million	701,683 Added 589.46%	820,722 $7.18 Million
Q1 2023 May 15, 2023	BUY	$7.91 - $12.0 $470,660 - $714,024	59,502 Added 99.94%	119,039 $1.41 Million
Q4 2022 Feb 14, 2023	BUY	$4.62 - $10.18 $80,850 - $178,150	17,500 Added 41.63%	59,537 $606,000
Q3 2022 Nov 15, 2022	BUY	$1.87 - $6.42 $41,514 - $142,524	22,200 Added 111.91%	42,037 $248,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.0 $215,100 - $430,200	-143,400 Reduced 87.85%	19,837 $49,000
Q1 2022 May 16, 2022	BUY	$2.83 - $6.7 $3,446 - $8,160	1,218 Added 0.75%	163,237 $485,000
Q4 2021 Feb 14, 2022	BUY	$5.65 - $10.73 $65,986 - $125,315	11,679 Added 7.77%	162,019 $1.15 Million
Q3 2021 Nov 15, 2021	BUY	$7.22 - $13.46 $156,219 - $291,234	21,637 Added 16.81%	150,340 $1.57 Million
Q2 2021 Aug 16, 2021	BUY	$12.26 - $22.0 $368,486 - $661,232	30,056 Added 30.47%	128,703 $1.58 Million
Q1 2021 May 17, 2021	BUY	$17.13 - $27.25 $1.69 Million - $2.69 Million	98,647 New	98,647 $2.17 Million

Others Institutions Holding TERN

# of Institutions

167

Shares Held

78.3M

Call Options Held

580K

Put Options Held

454K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $218M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Terns Pharmaceuticals, Inc. Transaction History